Microlearning Series
Did you know that Respiratory Syncytial Virus (RSV) accounts for approximately 85% of acute bronchiolitis cases in infants under 12 months of age?
While RSV is a leading cause of hospitalization and can be life-threatening in young children, its impact may extend far beyond the acute infection. Growing evidence suggests that early-life RSV infection could influence respiratory health for years to come, potentially affecting lung development and increasing the risk of wheezing, asthma, and impaired lung function.
Explore the latest evidence in just minutes
This microlearning module combines concise expert video insights with interactive quiz questions to help you understand the current research on the potential long-term consequences of RSV infection in infants and young children.
You’ll gain practical, evidence-based knowledge on how RSV may shape respiratory health trajectories and what this means for clinical practice.
Meet the expert
Dr. Valentina Fainardi
Content has been developed and reviewed by Dr. Valentina Fainardi, Assistant Professor at the University of Parma, Italy, who provides a clear overview of the latest evidence surrounding RSV and its potential long-term implications.
What you will explore
- Describe the short-term outcomes of RSV infection in infants and children.
- Explain the potential long-term respiratory consequences of early-life RSV infection, including:
- Recurrent wheezing
- Asthma
- Altered lung function
